The Japanese Journal of Clinical Dialysis Vol.41 No.10 ( Sep, 2025)

Thesis List

• 1 The gradation changes of clinical features in pneumonia among patients with hemodialysis -- Until the initiation of empiric therapy for CAP/NHCAP
  Yuji Hirai

• 2 Tuberculosis and nontuberculous mycobacterial infections in dialysis patients
  Mikio Takamori

• 3 Respiratory fungal infections in patients with dialysis : A review
  Chiaki Kasahara

• 4 Influenza and COVID-19
  Ayumi Yoshifuji

• 5 Standard infection prevention measures and environmental measures for respiratory infections
  Ryoichi Ando

• 6 Vaccination against respiratory tract infections in dialysis patients
  Tomoyuki Fujikura

• 7 Key points of hemodialysis nursing during respiratory infection outbreaks
  Kunie Nakano

• 8 Nutrition therapy and rehabilitation for patients with aspiration pneumonia
  Keisuke Maeda

• 10 Pharmacological characteristics of tenapanor hydrochloride and future perspectives in the pharmacotherapy of hyperphosphatemia
  Nobuo Nagano

• 11 Frequency of tenapanor stop due to soft stool and/or diarrhea, and an experience of the patient who had changed medication timing tenapanor of to only non-dialysis days
  Akihiko Kato

• 12 Experience with the addition of tenapanor hydrochloride to original phosphate binders for achieving strict serum phosphate control
  Masatomo Taniguchi

• 13 Clinical experience of reducing total pill burden with tenapanor hydrochloride in hemodialysis patients
  Shunsuke Yamada

• 14 A case of hyperphosphatemia treated with tenapanor alone
  Shunsuke Goto

• 15 Clinical experience of inadequate phosphate control despite administration of tenapanor hydrochloride
  Keisuke Soeda

• 16 Clinical experience showing a trend toward improved phosphate control with six months of tenapanor hydrochloride in a patient with persistent hyperphosphatemia due to frequent snacking
  Koji Matsuo

• 17 Clinical experience with tenapanor hydrochloride enabling dose reduction or discontinuation of laxatives
  Miho Murashima

• 18 Clinical experience in which co-administration of antidiarrheal agents enabled continued use of tenapanor hydrochloride
  Masaki Abe

• 19 Clinical experience with tenapanor hydrochloride in patients undergoing peritoneal dialysis
  Yukio Maruyama

Series List